Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Life Science

• Publication date

  2016-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.lfs.2016.01.009PMID 26776834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

  2015cited by this paper
• Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.

  2014cited by this paper
• New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

  2013cited by this paper
• Endothelin 1 in cancer: biological implications and therapeutic opportunities

  2013cited by this paper
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-like Cells

  2013cited by this paper
• Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells

  2013cited by this paper
• β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling

  2013cited by this paper
• Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation*

  2012cited by this paper
• Molecular Pathways Molecular Pathways : Vasculogenic Mimicry in Tumor Cells : Diagnostic and Therapeutic Implications

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.

  2012cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.

  2011cited by this paper
• Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells

  2011cited by this paper
• β-Arrestin-mediated receptor trafficking and signal transduction.

  2011cited by this paper
• Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell‐like profile

  2011cited by this paper
• Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

  2010cited by this paper
• Endothelin B Receptor, a New Target in Cancer Immune Therapy

  2009cited by this paper
• Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade.

  2009cited by this paper
• β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Angiogenesis, Vasculogenesis, and Vasculogenic Mimicry in Ovarian Cancer

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

  2008cited by this paper
• Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

  2006cited by this paper
• Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation.

  2002cited by this paper
• The Clinical Significance of Tumor Cell-Lined Vasculature in Ovarian Carcinoma: Implications for Anti-Vasculogenic Therapy

  2002cited by this paper
• Molecular determinants of ovarian cancer plasticity.

  2001cited by this paper
• Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

  2000cited by this paper
• Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

  1999cited by this paper

• Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells

  2023cites this paper
• Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma

  2022cites this paper
• Epstein-Barr Virus Regulates Endothelin-1 Expression through the ERK/FOXO1 Pathway in EBV-Associated Gastric Cancer

  2022cites this paper
• Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1

  2022cites this paper
• Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma

  2021cites this paper
• Blockade of endothelin receptor A enhances the therapeutic efficacy of gemcitabine in pancreatic cancer cells.

  2020cites this paper
• Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer

  2020cites this paper
• Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

  2020cites this paper
• Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration

  2020cites this paper
• Ag-Catalyzed selective fluorination of 6-substituted 2-amionpyrazines

  2019cites this paper
• β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer

  2019cites this paper
• Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer

  2018cites this paper
• β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells

  2017cites this paper
• Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer

  2017cites this paper
• Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts

  2017cites this paper
• Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia

  2017cites this paper
• β-arrestin1 at the cross-road of endothelin-1 signaling in cancer

  2016cites this paper